1. Home
  2. EVEX vs PHAT Comparison

EVEX vs PHAT Comparison

Compare EVEX & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$2.90

Market Cap

835.9M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.68

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVEX
PHAT
Founded
2020
2018
Country
United States
United States
Employees
198
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
835.9M
894.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVEX
PHAT
Price
$2.90
$11.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$6.88
$19.83
AVG Volume (30 Days)
1.2M
1.3M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
N/A
$175,110,000.00
Revenue This Year
N/A
$93.04
Revenue Next Year
$11,676.47
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$2.34
$2.21
52 Week High
$7.70
$18.31

Technical Indicators

Market Signals
Indicator
EVEX
PHAT
Relative Strength Index (RSI) 56.36 48.53
Support Level $2.86 $10.47
Resistance Level $3.18 $13.04
Average True Range (ATR) 0.15 0.92
MACD 0.02 -0.12
Stochastic Oscillator 53.76 50.64

Price Performance

Historical Comparison
EVEX
PHAT

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: